Table 1 Clinico-pathological characteristics and epidemiologic data of the series of MPM patients
Exploration series (n = 63) | Validation series (n = 110) | |
---|---|---|
Gender (n [%]) | ||
Male | 47 [75] | 85 [77] |
Female | 16 [25] | 25 [23] |
Age (years) | ||
Median ± SD | 64 ± 10 | 71 ± 11 |
Range | 39–90 | 20–89 |
Histology (n [%]) | ||
Epithelioid | 49 [78] | 81 [76] |
Biphasic | 7 [11] | 15 [8] |
Sarcomatoid | 5 [8] | 8 [7] |
Desmoplastic | 1 [2] | 2 [2] |
Lymphohistiocytoid | 1 [2] | 0 [0] |
Asbestos exposure (n [%]) | ||
Exposed | 47 [78] | 75 [74] |
Non-exposed | 13 [22] | 26 [26] |
Stage IMIG (n [%]) | ||
I | 2 [4] | 3 [6] |
II | 7 [14] | 8 [16] |
III | 25 [49] | 23 [45] |
IV | 17 [33] | 17 [33] |
Survival (months) | ||
Median | 16.9 | 19.7 |
Range | 0.1–165.7 | 0.4–108.5 |